个人中心
登出
中文简体
返回
-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
登录后咨询在线客服
回到顶部
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
周五盘中有12只医疗保健类股走势
Gainers
- Regencell Bioscience (NASDAQ:RGC) shares rose 175.07% to $17.33 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 277.4K shares, making up 587.65% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $219.1 million.
- Geovax Labs (NASDAQ:GOVX) stock rose 53.95% to $6.62. The current volume of 76.0 million shares is 9643.03% of Geovax Labs's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $41.8 million.
- XTL Biopharmaceuticals (NASDAQ:XTLB) shares rose 16.59% to $4.63. As of 12:30 EST, this security is trading at a volume of 1.2 million shares, making up 1217.01% of its average full-day volume over the last 100 days. The company's market cap stands at $24.4 million.
- Organovo Holdings (NASDAQ:ONVO) shares rose 15.29% to $7.01. The current volume of 180.1K shares is 78.59% of Organovo Holdings's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $61.0 million.
- Accelerate Diagnostics (NASDAQ:AXDX) stock increased by 13.73% to $6.21. As of 12:30 EST, this security is trading at a volume of 172.4K shares, making up 107.93% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $381.9 million.
- Allogene Therapeutics (NASDAQ:ALLO) stock moved upwards by 13.25% to $23.8. Trading volume for this security as of 12:30 EST is 849.6K, which is 69.54% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.3 billion.
Losers
- Progenity (NASDAQ:PROG) shares decreased by 55.45% to $0.66 during Friday's regular session. The current volume of 32.6 million shares is 1332.46% of Progenity's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $52.7 million.
- Sonnet BioTherapeutics (NASDAQ:SONN) stock declined by 50.28% to $0.61. The current volume of 38.9 million shares is 935.01% of Sonnet BioTherapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $12.9 million. The company's, Q3 earnings came out 4 days ago.
- Endo International (NASDAQ:ENDP) shares declined by 36.06% to $2.27. As of 12:30 EST, this security is trading at a volume of 23.9 million shares, making up 419.45% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $530.0 million.
- Sonoma Pharmaceuticals (NASDAQ:SNOA) stock declined by 24.05% to $6.19. Sonoma Pharmaceuticals's stock is trading at a volume of 3.3 million shares as of 12:30 EST. This is 172.67% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.9 million. As per the news, the Q1 earnings report came out 4 days ago.
- Fate Therapeutics (NASDAQ:FATE) stock fell 19.39% to $69.03. As of 12:30 EST, this security is trading at a volume of 3.6 million shares, making up 406.06% of its average full-day volume over the last 100 days. The company's market cap stands at $6.5 billion.
- Ensysce Biosciences (NASDAQ:ENSC) stock decreased by 18.02% to $3.14. Trading volume for Ensysce Biosciences's stock is 1.0 million as of 12:30 EST. This is 47.6% of its average full-day volume over the last 100 days. The company's market cap stands at $76.1 million.
Gainers
赢家
- Regencell Bioscience (NASDAQ:RGC) shares rose 175.07% to $17.33 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 277.4K shares, making up 587.65% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $219.1 million.
- Geovax Labs (NASDAQ:GOVX) stock rose 53.95% to $6.62. The current volume of 76.0 million shares is 9643.03% of Geovax Labs's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $41.8 million.
- XTL Biopharmaceuticals (NASDAQ:XTLB) shares rose 16.59% to $4.63. As of 12:30 EST, this security is trading at a volume of 1.2 million shares, making up 1217.01% of its average full-day volume over the last 100 days. The company's market cap stands at $24.4 million.
- Organovo Holdings (NASDAQ:ONVO) shares rose 15.29% to $7.01. The current volume of 180.1K shares is 78.59% of Organovo Holdings's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $61.0 million.
- Accelerate Diagnostics (NASDAQ:AXDX) stock increased by 13.73% to $6.21. As of 12:30 EST, this security is trading at a volume of 172.4K shares, making up 107.93% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $381.9 million.
- Allogene Therapeutics (NASDAQ:ALLO) stock moved upwards by 13.25% to $23.8. Trading volume for this security as of 12:30 EST is 849.6K, which is 69.54% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.3 billion.
- 脑再生科技纳斯达克(Sequoia Capital:RGC)股价在周五的例会中上涨175.07%,至17.33美元。截至美国东部时间12:30,该证券成交量为277.4K股,占其过去100日全天平均成交量的587.65。他们流通股的市值为2.191亿美元。
- GeoVax实验室纳斯达克(Youku)股价上涨53.95%,至6.62美元。目前的成交量为7,600万股,是GeoVax实验室过去100日平均全天成交量的9643.03%(最近一次更新是在美国东部时间12:30)。他们流通股的市值为4180万美元。
- XTL生物制药公司纳斯达克(Youku)股价上涨16.59%,至4.63美元。截至美国东部时间12:30,该证券成交量为120万股,占其过去100日全天平均成交量的1217.01。该公司的市值为2,440万美元。
- Organovo Holdings纳斯达克股票代码:ONVO)股价上涨15.29%,至7.01美元。目前180.1K股的成交量是Organovo Holdings过去100天全天平均成交量的78.59%(最后更新于美国东部时间12:30)。该公司的市值为6,100万美元。
- 加速诊断纳斯达克(Tmall:AXDX)股价上涨13.73%,至6.21美元。截至美国东部时间12:30,该证券成交量为172.4K股,占其过去100日全天平均成交量的107.93。他们流通股的市值为3.819亿美元。
- 同种异体基因治疗纳斯达克:ALLO)股价上涨13.25%,至23.8美元。截至美国东部时间12:30,该证券的成交量为849.6K,是过去100天全天平均成交量的69.54%。他们流通股的市值为33亿美元。
Losers
失败者
- Progenity (NASDAQ:PROG) shares decreased by 55.45% to $0.66 during Friday's regular session. The current volume of 32.6 million shares is 1332.46% of Progenity's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $52.7 million.
- Sonnet BioTherapeutics (NASDAQ:SONN) stock declined by 50.28% to $0.61. The current volume of 38.9 million shares is 935.01% of Sonnet BioTherapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $12.9 million. The company's, Q3 earnings came out 4 days ago.
- Endo International (NASDAQ:ENDP) shares declined by 36.06% to $2.27. As of 12:30 EST, this security is trading at a volume of 23.9 million shares, making up 419.45% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $530.0 million.
- Sonoma Pharmaceuticals (NASDAQ:SNOA) stock declined by 24.05% to $6.19. Sonoma Pharmaceuticals's stock is trading at a volume of 3.3 million shares as of 12:30 EST. This is 172.67% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.9 million. As per the news, the Q1 earnings report came out 4 days ago.
- Fate Therapeutics (NASDAQ:FATE) stock fell 19.39% to $69.03. As of 12:30 EST, this security is trading at a volume of 3.6 million shares, making up 406.06% of its average full-day volume over the last 100 days. The company's market cap stands at $6.5 billion.
- Ensysce Biosciences (NASDAQ:ENSC) stock decreased by 18.02% to $3.14. Trading volume for Ensysce Biosciences's stock is 1.0 million as of 12:30 EST. This is 47.6% of its average full-day volume over the last 100 days. The company's market cap stands at $76.1 million.
- 繁衍后代纳斯达克(Sequoia Capital:PROG)股价在周五的例会中下跌55.45%,至0.66美元。目前成交量为3,260万股,是Progenity过去100日全天平均成交量的1332.46%(最近一次更新是在美国东部时间12:30)。他们流通股的市值为5270万美元。
- 十四行诗生物治疗学纳斯达克股价下跌50.28%,至0.61美元。目前3,890万股的成交量是Sonnet BioTreateutics过去100日平均全天成交量的935.01%(最近一次更新是在美国东部时间12:30)。该公司的市值为1,290万美元。该公司第三季度财报于4天前公布。
- 远藤国际纳斯达克(Sequoia Capital:ENDP)股价下跌36.06%至2.27美元。截至美国东部时间12:30,该证券成交量为2,390万股,占其过去100日全天平均成交量的419.45。他们流通股的市值为5.3亿美元。
- 索诺马制药公司纳斯达克(SNOA)股价下跌24.05%,至6.19美元。截至美国东部时间12:30,Sonoma PharmPharmticals的股票交易量为330万股。这是过去100日平均全天成交量的172.67%。他们流通股的市值为1290万美元。根据消息,第一季度收益报告是在4天前发布的。
- 命运治疗公司纳斯达克股价下跌19.39%,至69.03美元。截至美国东部时间12:30,该证券成交量为360万股,占其过去100日全天平均成交量的406.06。该公司的市值为65亿美元。
- Ensysce生物科学纳斯达克(Sequoia Capital:ENSC)股价下跌18.02%,至3.14美元。截至美国东部时间12:30,Ensysce Biosciences的股票成交量为100万股。这是其过去100天全天平均成交量的47.6%。该公司的市值为7610万美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
风险及免责提示
本页的译文内容由软件翻译。Moomoo将竭力但却不能保证翻译内容之准确和可靠,亦不会承担因任何不准确或遗漏而引起的任何损失或损害。
本内容仅用作提供信息及教育之目的,不构成对任何特定证券或投资策略的推荐或认可。本内容中的信息仅用于说明目的,可能不适用于所有投资者。本内容未考虑任何特定人士的投资目标、财务状况或需求,并不应被视作个人投资建议。建议您在做出任何投资于任何资本市场产品的决定之前,应考虑您的个人情况判断信息的适当性。过去的投资表现不能保证未来的结果。投资涉及风险和损失本金的可能性。moomoo对上述内容的真实性、完整性、准确性或对任何特定目的的时效性不做任何陈述或保证。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
知道了
抢沙发
0 0 0
赞大爱笑哭社会社会Emm心碎怒
轻触选择心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧
点击这里分享给好友
暂无评论,快来抢沙发吧!